Vicarious Surgical (RBOT) Net Income towards Common Stockholders (QoQ) (2020 - 2025)
Analysis
Vicarious Surgical (RBOT) Net Income towards Common Stockholders (QoQ) (2020 - 2025) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.04 Bn | 177.44 Bn | 7.27 Bn |
| 2 | Intuitive Surgical | 125.02 Bn | 119.81 Bn | 1.96 Bn |
| 3 | Medtronic | 117.84 Bn | 109.02 Bn | 6.34 Bn |
| 4 | Stryker | 105.50 Bn | 102.02 Bn | 4.50 Bn |
| 5 | Boston Scientific | 66.27 Bn | 65.73 Bn | 3.85 Bn |
| 6 | Edwards Lifesciences | 49.60 Bn | 45.35 Bn | 1.35 Bn |
| 7 | Alcon | 33.70 Bn | 32.24 Bn | 1.68 Bn |
| 8 | Dexcom | 32.06 Bn | 30.11 Bn | 830.00 Mn |
| 9 | Steris | 21.02 Bn | 20.54 Bn | 684.20 Mn |
| 10 | Vicarious Surgical | 231,626.35 | -14.81 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2025 | 16.32% |
| Jun 30, 2025 | 14.15% |
| Mar 31, 2025 | -10.54% |
| Dec 31, 2024 | 18.52% |
| Sep 30, 2024 | -12.40% |
| Jun 30, 2024 | 10.56% |
| Mar 31, 2024 | -29.67% |
| Dec 31, 2023 | 16.51% |
| Sep 30, 2023 | -2.41% |
| Jun 30, 2023 | 43.04% |
| Mar 31, 2023 | -140.81% |
| Dec 31, 2022 | 54.80% |
| Sep 30, 2022 | -1,602.48% |
| Jun 30, 2022 | -103.42% |
| Mar 31, 2022 | 95.20% |
| Dec 31, 2021 | 148.28% |
| Sep 30, 2021 | -579.78% |
| Jun 30, 2021 | -26.90% |
| Mar 31, 2021 | -38.24% |
| Dec 31, 2020 | -13.26% |